Skip to content

    Fortress Biotech (FBIO) financials

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+18.4% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $14.63M
    $15.12M
    $13.14M
    $16.41M
    $17.63M
    +20.5%
    $16.08M
    +6.3%
    $16.04M
    +22.1%
    $18.72M
    +14.0%
    Strengthening
    Operating Profit
    -$22.09M
    -$23.93M
    -$22.32M
    -$36.47M
    -$6.81M
    +69.2%
    -$4.62M
    +80.7%
    -$7.74M
    +65.3%
    -$10.01M
    +72.6%
    Strengthening
    Net Profit
    -$12.87M
    -$6.76M
    -$10.58M
    $15.49M
    $5.85M
    -$3.94M
    +41.8%
    $110.37M
    -$468.0K
    -103.0%
    Weakening
    EPS
    $-0.76
    $-0.48
    $0.50
    $0.13
    $3.44
    $-0.08
    -116.0%
    Weakening
    Other Income
    -$4.53M
    -$2.14M
    -$2.37M
    $24.82M
    $15.66M
    -$1.42M
    +33.5%
    $150.03M
    $10.93M
    -56.0%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    -$26.63M
    -$24.69M
    -$11.65M
    $8.85M
    -$6.04M
    $142.29M
    $922.0K
    Strengthening
    MarginsOPM
    -151.0%
    -158.3%
    -169.8%
    -222.2%
    -38.6%
    +74.4%
    -28.7%
    +81.8%
    -48.3%
    +71.6%
    -53.5%
    +75.9%
    Strengthening
    Tax
    -0.3%
    0.0%
    0.0%
    0.3%
    10.7%
    3.6%
    34.7%
    Strengthening
    ReturnsROIC
    2.1%
    1.1%
    1.7%
    -2.5%
    -0.9%
    -145.5%
    0.6%
    -41.8%
    -17.7%
    -1142.8%
    0.1%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$65.51M$136.86M$233.35M$305.74M$178.27M$80.93M$57.26M$79.38M$196.58M
    Short-Term Investments
    Total Current Assets$111.21M$156.25M$266.15M$346.46M$230.43M$117.02M$90.37M$123.84M$245.51M
    Net PP&E$12.02M$33.91M$32.41M$34.07M$33.01M$23.50M$17.12M$14.82M$13.77M
    Goodwill
    Intangibles$1.42M$7.38M$14.63M$12.55M$27.20M$20.29M$31.86M$27.61M$25.51M
    Total Assets$140.99M$226.42M$333.41M$396.50M$294.30M$167.53M$144.22M$185.55M$316.71M
    LiabilitiesTotal Current Liabilities$55.61M$45.62M$51.76M$101.04M$127.72M$84.91M$71.40M$49.74M$62.02M
    Short-Term Debt
    Long-Term Debt$84.41M$84.66M$51.68M$42.94M$91.73M$60.86M$57.96M$54.49M$35.00M
    Long-Term Leases$0$23.71M$22.89M$20.99M$21.57M$18.28M$14.75M$12.67M$11.47M
    Total Liabilities$121.25M$153.89M$136.41M$170.63M$244.28M$165.94M$145.87M$123.36M$110.63M
    EquityCommon Stock & APIC$58.0K$74.0K$95.0K$101.0K$7.0K$15.0K$28.0K$31.0K$33.0K
    Retained Earnings-$396.27M-$436.23M-$482.76M-$547.46M-$634.23M-$694.87M-$740.87M-$734.05M-$624.15M
    Total Equity$1.85M$26.21M$100.34M$108.67M$41.72M$22.54M$22.74M$49.87M$164.14M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$98.85M-$94.96M-$83.68M-$116.54M-$179.40M-$128.22M-$80.19M-$65.78M$125.92M
    Cash from Investing$18.82M$20.10M-$7.16M$40.51M-$22.93M-$2.10M-$15.00M$10.12M$2.79M
    Cash from Financing$50.65M$146.71M$172.41M$148.99M$75.32M$32.74M$70.64M$77.44M-$6.52M
    SummaryCapital Expenditure-$7.08M-$2.35M-$1.93M-$4.57M-$2.71M-$63.0K$0
    Free Cash Flow-$105.93M-$97.31M-$85.61M-$121.11M-$182.12M-$128.29M-$80.19M
    FCF Margin-394.1%-265.7%-187.7%-176.0%-240.4%-151.8%-139.0%

    Ratios